Category: Washington Focus

DeLauro's House Bill to Restrict DTC Advertising Likely Would Violate First Amendment

CDER’s Woodcock Says FDA Is Meeting GDUFA Challenges at House Pricing Hearing

Industry More Than Ready for FDA Off-label Communications Guidance

Industry Prepares for DTC Battle

Are DTC Ads Being Mischaracterized?

Save the Date: PhRMA’s Lori Reilly to Speak to Coalition on Feb. 16

Coalition Arms Industry with Tool Kit to Defend DTC Advertising

NBER: DTC Ads Increase Treatment of the Undertreated and Undiagnosed, Improve Drug Adherence

Rocky Political Road Ahead for Pharma Industry